Business Wire

CA-ALTIUM

9.2.2021 03:21:04 CET | Business Wire | Press release

Share
Altium Empowers High School STEM Teachers with a Virtual Electronic Design Curriculum and Tools

In September 2020, Altium LLC, the leading printed circuit board (PCB) software company, launched Upverter Education , a free distance learning initiative to support STEM educators.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005934/en/

“Upverter Education has the opportunity to help high school STEM teachers transition into the virtual classroom. Our goal is to support the next generation of electronics designers of all economic levels by giving them access to free curriculum and professional tools today to prepare them for their innovative careers in the future,” explains Rea Callender, Executive Director of Upverter Education.

The Upverter Education initiative provides the curriculum and resources to guide users through the design, prototyping and manufacturing of electronics engineering concluding with the delivery of students hardware designs. Teachers can utilize the materials to supplement their existing lesson plans, either as standalone units or as a full, 4-6 week educational program.

The program centers around Altium’s Upverter , a free, web-based PCB design tool that’s easy to use in the distance-learning classroom. Upverter’s collaborative and remote capabilities align perfectly with the needs of STEM educators for guiding students through the electronics design process and their exploration of technology and engineering.

Since the launch, the Upverter Education team has formed strategic partnerships with schools around the country and collaborations with leaders in engineering education, including the American Society for Engineering Education, TRYEngineering, First Robotics, and NASA’s Robotics Alliance Project.

Schools within Elk Grove Unified, one of California’s largest school districts, have adopted the Upverter Education program, as well as the North Carolina School of Science and Mathematics (NCSSM), a two-year public residential high school in Durham, NC.

Marshall Massengill, robotics mentor and alumnus of NCSSM, explains how Upverter has been helping him promote remote learning statewide. “Currently with Covid-19, most of our students are spread throughout the state rather than living on campus. Upverter’s collaborative nature is helping transform the team and keep on working, just as we would normally in the lab.” The Upverter Teachers Guide provides step by step instructions for teachers to launch the program.

For Michael Rosales, Engineering and Science teacher at Elk Grove Unified Florin High School, Altium’s education program is already changing the way he teaches Principles of Engineering. “This is perfect for my class already--it allows the kids to look at virtual circuits before they create physical ones, and you can have multiple people working on one circuit together,” Rosales reports.

Educators are currently using the program to teach robotics, engineering, digital electronics design, principles of engineering and STEM intro classes. The Upverter Education team is also supporting high school students working on proposals for NASA’s CubeSat Launch Initiative program, extending the use of Upverter for small satellite payloads.

To see how teachers are using Upverter Education in the classroom, please visit: https://youtu.be/cJu0Qopwk2M

For a comprehensive overview of the Upverter Education distance learning program, please register for this informational webinar , scheduled for February 27, 2021.

About Upverter

Upverter is a free EDA system delivered in a web-browser, which enables students and educators to design, share, and review schematics and printed circuit boards. It provides the ability to generate a bill of materials, Gerber files, and 3D rendering. Upverter is an Altium brand. To learn more about Upverter and Upverter Education, visit https://education.upverter.com/ .

ABOUT ALTIUM

Altium LLC, a global software company headquartered in San Diego, CA is accelerating the pace of innovation through electronics. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers. From individual inventors to multinational corporations, more PCB designers and engineers choose Altium software to design and realize electronics-based products.

Social Media:

https://www.facebook.com/AltiumOfficial

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye